Shares of Companhia Brasileira de Distribuicao (NYSE:CBD) dropped 1.1% on Wednesday . The stock traded as low as $17.14 and last traded at $17.20, with a volume of 512,423 shares trading hands. The stock had previously closed at $17.40.

CBD has been the topic of several research analyst reports. Zacks Investment Research upgraded Companhia Brasileira de Distribuicao from a “sell” rating to a “hold” rating in a research note on Tuesday, June 14th. Deutsche Bank AG upgraded Companhia Brasileira de Distribuicao from a “hold” rating to a “buy” rating in a research note on Tuesday, June 7th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $10.17.

The company has a market capitalization of $4.57 billion and a price-to-earnings ratio of 59.55. The stock’s 50-day moving average is $13.85 and its 200 day moving average is $12.39.

An institutional investor recently raised its position in Companhia Brasileira de Distribuicao stock. Brandes Investment Partners LP increased its position in shares of Companhia Brasileira de Distribuicao (NYSE:CBD) by 5.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,095,051 shares of the company’s stock after buying an additional 110,038 shares during the period. Brandes Investment Partners LP owned 0.79% of Companhia Brasileira de Distribuicao worth $22,040,000 as of its most recent filing with the SEC.

Companhia Brasileira de Distribuicao, directly or through its subsidiaries, is engaged in the retail of food, clothing, home appliances, electronics and other items through its chain of hypermarkets, supermarkets, specialized stores and department stores. The Company’s operating segments include Retail segment, Cash and carry segment, Home appliances segment and E-commerce segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.